» Articles » PMID: 24792914

Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and MTORC1 Kinase Activation

Overview
Journal Immunity
Publisher Cell Press
Date 2014 May 6
PMID 24792914
Citations 445
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamine has been implicated as an immunomodulatory nutrient, but how glutamine uptake is mediated during T cell activation is poorly understood. We have shown that naive T cell activation is coupled with rapid glutamine uptake, which depended on the amino acid transporter ASCT2. ASCT2 deficiency impaired the induction of T helper 1 (Th1) and Th17 cells and attenuated inflammatory T cell responses in mouse models of immunity and autoimmunity. Mechanistically, ASCT2 was required for T cell receptor (TCR)-stimulated activation of the metabolic kinase mTORC1. We have further shown that TCR-stimulated glutamine uptake and mTORC1 activation also required a TCR signaling complex composed of the scaffold protein CARMA1, the adaptor molecule BCL10, and the paracaspase MALT1. This function was independent of IKK kinase, a major downstream target of the CARMA1 complex. These findings highlight a mechanism of T cell activation involving ASCT2-dependent integration of the TCR signal and a metabolic signaling pathway.

Citing Articles

Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?.

Kim J, Li J, Wei J, Lim S Immune Netw. 2025; 25(1):e13.

PMID: 40078783 PMC: 11896657. DOI: 10.4110/in.2025.25.e13.


Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice.

Wen Z, Liu T, Xu X, Acharya N, Shen Z, Lu Y Nat Commun. 2025; 16(1):2362.

PMID: 40064918 PMC: 11893787. DOI: 10.1038/s41467-025-57603-1.


[SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages].

Zou J, Wang H, Zhang D Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):269-284.

PMID: 40031971 PMC: 11875851. DOI: 10.12122/j.issn.1673-4254.2025.02.08.


Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review.

Jiang Y, Tao Q, Qiao X, Yang Y, Peng C, Han M Front Immunol. 2025; 16:1508730.

PMID: 40018041 PMC: 11864927. DOI: 10.3389/fimmu.2025.1508730.


Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


References
1.
Waickman A, Powell J . mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev. 2012; 249(1):43-58. PMC: 3419491. DOI: 10.1111/j.1600-065X.2012.01152.x. View

2.
Sarbassov D, Ali S, Sabatini D . Growing roles for the mTOR pathway. Curr Opin Cell Biol. 2005; 17(6):596-603. DOI: 10.1016/j.ceb.2005.09.009. View

3.
Fingar D, Salama S, Tsou C, Harlow E, Blenis J . Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 2002; 16(12):1472-87. PMC: 186342. DOI: 10.1101/gad.995802. View

4.
McGivan J, Bungard C . The transport of glutamine into mammalian cells. Front Biosci. 2006; 12:874-82. DOI: 10.2741/2109. View

5.
Blonska M, Lin X . CARMA1-mediated NF-kappaB and JNK activation in lymphocytes. Immunol Rev. 2009; 228(1):199-211. PMC: 2878635. DOI: 10.1111/j.1600-065X.2008.00749.x. View